DDIT3 and amyotrophic lateral sclerosis: First, we found that all three compounds promoted ALS MN survival (Fig. 6c) and significantly reduced expression of ER stress transcripts CHOP and sXBP1 in all the ALS MNs at day 31 (Fig. 6d–f).